“The scan looks good. The tumor has shrunk.” For patients and clinicians, these are genuinely welcome words. They can also become the weightiest words in a consultation, and sometimes the only ones remembered. Once the disease response is reassuring, the discussion naturally turns to the next scan, the next treatment, and prognosis. Fatigue, pain, swallowing problems, poor sleep, mobility, work, and strain at home may be left until the patient raises them. The risk is that, without meaning to, we let “the tumor is better” stand in for checking whether the patient is getting better.
These 2 forms of improvement are related, but they are not the same clinical outcome. Tumor response describes how the disease has responded to treatment. Recovery is lived through symptoms, function, emotions, social roles, and daily life. A study in Palliative & Supportive Care found that staff ratings had fair validity for physical items but poor validity for psychosocial items when used in place of patient self-report (Sakurai et al. Reference Sakurai, Miyashita and Morita2021). During radiation therapy for breast cancer, patients reported a higher overall symptom burden than clinicians. Agreement was particularly poor for fatigue and psychosocial concerns, and the discordance increased as treatment progressed (Lapen et al. Reference Lapen, King and Braunstein2022). Neither study tested whether a favorable result makes clinicians less likely to ask about symptoms. Their relevance here is simpler: disease status and clinician assessment cannot replace the patient’s account.
In practice, a scan may show stable disease, tumor shrinkage, or no progression while the patient continues to live with pain, fatigue, xerostomia, dysphagia, poor sleep, altered appearance, limited mobility, or difficulty resuming previous roles. We use the term “treatment response–patient recovery discordance” for this situation. The label is descriptive only. It is neither a diagnosis nor a validated scale or intervention model; it simply brings 2 different outcomes back into the same clinical conversation.
Good-response visits therefore deserve particular attention. Both patient and team have good reason to breathe more easily. That very relief can make other burdens feel less urgent. If a results visit accounts for the disease response but does not separately check the patient’s condition, supportive care may be left on hold until the patient raises the issue. Among patients receiving systemic cancer therapy, fear of recurrence was associated with anxiety, depression, and poorer quality of life (Andreis et al. Reference Andreis, Mirandola and Deori2025). That study did not compare distress with radiologic response, but its findings caution against assuming psychological security from disease control.
At important response or follow-up visits, we suggest keeping 2 lines of inquiry open. One asks, “What has happened to the disease?” The other asks, “How is the patient living now?” After explaining the response, a clinician might say: “This is good news about the tumor. But a better scan does not always mean that you feel better. Apart from the scan result, what has affected your life most recently?” If the patient wishes to continue, the conversation can stay with 3 areas: the symptom causing the most trouble, a function not yet regained, and what matters most in the next phase. No score is required, and the question is not intended as another screening instrument. It is a brief way to keep the disease response from answering for the patient.
Formal patient-reported outcome measures (PROMs) remain valuable. Clinical guidance and a systematic review support their routine use in oncology for symptom recognition, patient–clinician communication, and care decisions (Graupner et al. Reference Graupner, Kimman and Mul2021; Di Maio et al. Reference Di Maio, Basch and Denis2022). Recent work in Palliative & Supportive Care found that systematic collection of patient-reported symptoms and problems helped clinicians identify concerns, structure the conversation, and initiate appropriate action (Ikander et al. Reference Ikander, Bergenholtz and Sørensen2025). Established measures and pathways should be used where available. Even when a complete measure cannot be administered at every visit, clinicians can still ask 1 explicit question. Whether 1 question or a full measure is used, disease response and patient recovery need to be checked separately.
Radiation therapy makes the problem easy to see, but it is not unique to radiation oncology. After treatment, imaging may show a favorable response, yet dysphagia, xerostomia, fatigue, reduced mobility, changes in appearance, or difficulty returning to work and family roles may not follow the imaging timetable. The radiation oncologist explains the disease and treatment response. Nursing, nutrition, rehabilitation, psychosocial, and palliative care teams address different supportive needs. The radiation therapist has a more limited but not peripheral role: daily treatment contact can reveal changes in function and tolerance and help route concerns to the appropriate team. What matters is not which professional asks 1 more question, but that the team does not take “the treatment worked” to mean “support can stop.”
The boundaries matter. Not every good result warrants a palliative care referral, and not every patient with persistent fatigue, worry, or functional limitation needs more intensive intervention. Patients are entitled to enjoy good news and to say that they need nothing else at present. If pain, anxiety, functional, nutritional, family, or role-related concerns emerge, assessment and referral can proceed through established pathways according to severity and preference. Supportive care does not turn good news into a problem. It keeps success in oncology from becoming an automatic reason to stop asking.
Imaging can tell us how a tumor has responded to treatment. Only the patient can tell us whether life has caught up. A favorable disease response may resolve one part of the uncertainty; it should not end clinical inquiry. The most practical response is not to create another system, but to leave room after the good news for 1 sentence from the patient: “I know the result is good, but I am not better yet.”
Acknowledgments
The authors used OpenAI ChatGPT (GPT-5.4 Thinking; accessed through ChatGPT on 10 August 2026) for English-language refinement and translation of the author-developed Chinese manuscript text into English during manuscript preparation. The authors reviewed and revised all output, rechecked the references, and take full responsibility for the final content.
Funding
This work received no specific grant from any funding agency, commercial entity, or not-for-profit organization.
Competing interests
The authors declare none.